Martin Marro

Company: Eli Lily

Job title: Executive Director, Cell Pharmacology, Obesity & Complications

Bio:

Martin Marro, based in Boston, MA, US, is currently a Executive Director – Cell Pharmacology, Obesity and Complications at Eli Lilly and Company. Martin Marro brings experience from previous roles at Tectonic Therapeutic, Inc. and Novartis Institutes for BioMedical Research (NIBR). Martin Marro holds a PhD in Molecular Genetics @ International Centre for Genetic Engineering & Biotechnology (ICGEB). With a robust skill set that includes Molecular Biology, Biotechnology, Pharmacology, Cell Biology, Biochemistry and more.

Seminars:

Optimizing GLP-1/GIP Dual Agonism for Enhanced Weight Loss & Metabolic Control to Deliver Superior Patient Outcome 9:00 am

Leveraging co-agonist mechanisms for synergistic receptor activation to maximize therapeutic efficacy for profound and sustained weight reduction Characterizing differential receptor potency for tailored pharmacological profiles to improve tolerability for broader patient applicability Leveraging large-scale clinical evidence to demonstrate comprehensive metabolic benefits, which establishes new standards of care for transformative patient outcomesRead more

day: Day One